ATRL:TSXAtkinsrealis Group Inc. Analysis
Data as of 2026-05-13 - not real-time
CA$88.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
AtkinsRéalis Group Inc. trades well below analyst target prices despite a P/E ratio that is a fraction of the industry average, indicating a substantial valuation gap. The stock benefits from a solid balance sheet, strong cash generation and a remarkably low dividend payout, suggesting dividend sustainability. Recent strategic acquisitions in Australia and the defence sector broaden the company’s geographic footprint and deepen its exposure to high‑growth infrastructure and power‑renewables markets. However, technical signals are mixed: the 20‑day SMA sits just above the current price, the MACD has turned bearish and volume is on a downtrend, pointing to short‑term pressure. The market sentiment index shows “Extreme Greed,” which may be inflating price momentum beyond fundamentals.
Overall, the fundamentals point to a resilient, cash‑rich business with attractive earnings yields, yet the current price appears stretched relative to discounted cash‑flow estimates, implying limited upside in the near term but potential upside if the valuation gap narrows over a longer horizon.
Overall, the fundamentals point to a resilient, cash‑rich business with attractive earnings yields, yet the current price appears stretched relative to discounted cash‑flow estimates, implying limited upside in the near term but potential upside if the valuation gap narrows over a longer horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and decreasing volume suggest limited upside
- Price is near the identified support level
- Acquisition announcements may be priced in already
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash flow and low payout ratio support earnings stability
- Strategic acquisitions expand market presence in high‑growth regions
- Valuation still above DCF fair value, limiting upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and operating margins indicate durable profitability
- Diversified global footprint reduces reliance on any single market
- Potential re‑rating as valuation gap narrows over time
Key Metrics & Analysis
Financial Health
Revenue Growth13.40%
Profit Margin23.89%
P/E Ratio5.8
ROE56.49%
ROA3.81%
Debt/Equity23.49
P/B Ratio2.7
Op. Cash FlowCA$461.3M
Free Cash FlowCA$477.4M
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI41.3
SupportCA$87.41
ResistanceCA$98.24
MA 20CA$92.59
MA 50CA$92.11
MA 200CA$94.29
MACDBearish
VolumeDecreasing
Fear & Greed Index89.36
Valuation
Fair ValueCA$67.12
Target PriceCA$115.60
Upside/Downside30.03%
GradeOvervalued
TypeValue
Dividend Yield0.09%
Risk Assessment
Beta1.06
Volatility32.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.